Lymphoma, T-Cell - 42 Studies Found
Recruiting |
: Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma :
|
Terminated |
: CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma : T-cell Lymphoma : 2009-05-05 :
|
Not yet recruiting |
: Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients : Peripheral T Cell Lymphoma : 2016-11-03 :
|
Recruiting |
: Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study : Peripheral T-cell Lymphomas : 2015-07-26 :
|
Recruiting |
: Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas :
: 2014-12-12 :
|
Completed |
: Treatment of Peripheral T-cell Lymphoma : Peripheral T-cell Lymphoma : 2012-08-10 :
|
Completed |
: CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma : Peripheral T-Cell Lymphoma : 2013-02-25 : Drug: Alemtuzumab Consolidation after CHOP induction |
Completed |
: Study of Bortezomib Combined With ACVBP in Peripheral T-Cell Lymphoma : Peripheral T-Cell Lymphoma : 2005-08-26 : Drug: Velcade + ACVBP regimen |
Active, not recruiting |
: A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma : Peripheral T-cell Lymphoma : 2007-01-23 : Drug: Romidepsin Romidepsin intravenously (through a vein) over 4 hours on Days 1, 8 and 15 of each 28-d |
Completed |
: Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL) : Peripheral T-Cell Lymphoma : 2012-05-30 : Biological: KW-0761 (mogamulizumab) 1 mg/kg administered intravenously weekly x 4 then every other week |